Expert Insights Advisors

What Expert Insights Advisors does

Expert Insights Advisors (legal entity Expert Insights Consulting LLC) is a US-based, operator-led advisory firm serving the pharma services, healthcare, and life sciences ecosystem. Founded in 2016 and headquartered in Naples, Florida, the firm positions itself as a sector-deep alternative to generalist consultancies and bulge-bracket advisors, deploying a curated network of 300+ Senior Advisors (former healthcare and life sciences executives) alongside Execution Partners and Ecosystem Partners to deliver engagements to financial sponsors, strategic operators, and emerging/growth companies.

The firm's offering is organized along two axes: eight sector verticals (Pharma Services, Drug Development, Commercial & Post-Approval, Medical & Healthcare Technology, Nutraceuticals & Supplements, OTC & Consumer Health, Healthcare Distribution & Logistics, and Investor-Relevant Vertical Themes) and more than twenty capabilities spanning transaction advisory (buy-side, sell-side, confirmatory due diligence, deal sourcing, asset divestitures), transformation work (commercial transformation, operations transformation, strategic portfolio review, capacity and expansion planning), and talent/board services (executive and commercial search, board advisory, expert network access). The firm cites 5,000+ client engagements and $20B+ in advised transactions as its track record; there is no proprietary technology platform, no AI product, and no disclosed patents.

Expert Insights generates revenue through professional services delivered on a custom, engagement-based pricing model with multi-year contract cadences typical of retainer-style mandates. Distribution is enterprise field sales: direct relationship-building with PE/VC sponsors and large healthcare operators, supplemented by LinkedIn, industry events, website/SEO, and network-driven referrals from the senior advisor base. The firm is privately held with no disclosed external funding, parent company, or institutional investor, and reports no M&A activity or restructuring to date.

Name

Expert Insights Advisors

Legal name

Expert Insights Consulting LLC

Website

https://expertinsightsadvisors.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

Expert Insights Advisors is a US-based, operator-led advisory firm serving financial sponsors, strategic operators, and growth companies across pharma services, healthcare, and life sciences with sector-deep consulting across transactions, commercial transformation, and value creation.

Ownership category

akta.pro rank

Product category

Healthcare & Life Sciences Advisory

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ)

akta.pro secondary industries

Buy-Side M&A Advisory (FSAEAGAB), Sell-Side M&A Advisory (FSAEAGAA), M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA)

Keywords

• Pharma advisory services
• Healthcare transaction advisory
• Life sciences consulting
• Buy-side advisory
• Sell-side advisory

Headquarters

HQ city

Naples

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. Advisory and Consulting Services: Expert Insights generates revenue through professional advisory services delivered to financial sponsors, strategic operators, and growth companies. The firm provides end-to-end advisory across transactions, strategic growth initiatives, and value creation. Engagement models include project-based consulting, board advisory, confirmatory due diligence, buy-side and sell-side transaction advisory, and executive search services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Expert Insights Advisors is a global, operator-led advisory firm providing transaction, strategic growth, and value creation advisory services across Pharma Services, Healthcare, and Life Sciences. The firm engages with financial sponsors, strategic operators, and growth-stage companies to execute buy-side and sell-side M&A, asset divestitures, commercial transformation, market entry, and operational efficiency initiatives. Service delivery is powered by a curated network of 300+ former C-suite and senior industry executives who collectively have completed 5,000+ client engagements and advised on more than $20B in healthcare transactions.

Product overview

Expert Insights Advisors operates as a global advisory firm providing operator-led consulting services across Pharma Services, Healthcare, and Life Sciences sectors. Rather than a unified software platform, the company offers a portfolio of advisory service capabilities organized around sector expertise (Pharma Services, Drug Development, Commercial & Post-Approval, Medical & Healthcare Technology, Nutraceuticals, OTC & Consumer Health, Distribution & Logistics, and Investor Themes) and transaction/growth capabilities (Asset Divestitures, Buy-Side Advisory, Sell-Side Advisory, Commercial Transformation, Operations Transformation, Market Entry Strategy, Strategic Portfolio Review, and Expert Network access). The firm serves Financial Sponsors, Strategic Operators, and Emerging & Growth Companies through a network of 300+ Senior Advisors who have completed over 5,000 client engagements and advised on $20B+ in transactions.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharma Services Advisory Sector-focused advisory for pharmaceutical services providers covering strategy consulting, transaction support, and operational excellence initiatives.
• Drug Development Services Advisory Advisory across the drug development lifecycle including clinical development, regulatory strategy, and commercialization planning for pharma and biotech clients.
• Commercial & Post-Approval Services Advisory Advisory for commercial strategy, market access, and post-approval lifecycle management of pharmaceutical products.
• Medical & Healthcare Technology Advisory Advisory for medical device, diagnostics, and healthcare technology companies on strategy, growth, and value creation.
• Nutraceuticals & Supplements Advisory Advisory for nutraceutical and dietary supplement companies covering regulatory compliance, market entry, and commercial strategy.
• OTC & Consumer Health Advisory Advisory for over-the-counter and consumer health products including brand strategy and market expansion.
• Healthcare Distribution & Logistics Advisory Advisory for healthcare supply chain, distribution, and logistics companies on operational efficiency and strategic growth.
• Asset Divestitures Advisory Advisory services for planning and executing asset divestitures in the healthcare and life sciences sector.
• Buy-Side Advisory & Value Creation Advisory for investors acquiring healthcare assets with focus on value creation and post-acquisition strategy.
• Sell-Side Transaction Advisory Advisory services for companies selling healthcare and life sciences assets, including positioning and transaction execution.
• Commercial Transformation Advisory Advisory services for transforming commercial operations including go-to-market strategy and sales force optimization.
• Operations Transformation Advisory Advisory for operational efficiency improvements and network optimization in healthcare organizations.
• Market Entry & Growth Strategy Advisory Strategic advisory for entering new markets and achieving sustainable growth in healthcare sectors.
• Strategic Portfolio Review Advisory services for evaluating and optimizing product and business portfolios in healthcare companies.
• Board Advisory Board-level advisory services providing senior industry perspective to healthcare company boards on strategy and governance.
• Confirmatory Due Diligence Independent confirmatory due diligence services for healthcare and life sciences transactions.
• Executive & Commercial Search Executive and commercial talent search services for healthcare and life sciences organizations.
• Expert Network Access Client access to the firm's curated network of 300+ senior advisors and former healthcare executives for strategic guidance.

Quantifiable outcome

• $20B+ in transactions advised across pharma, healthcare, and life sciences
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and supporting.

• Senior AdvisorscoreOthersCurated network of 300+ former executives from pharma, healthcare, and life sciences industries who provide advisory services to clients. These advisors are independent professionals who collaborate with Expert Insights on client engagements.
• Execution PartnerssupportingImplementation/ SI/ Consulting PartnerImplementation and execution partners that collaborate with Expert Insights to deliver integrated advisory services to clients across complex transactions and strategic initiatives.
• Ecosystem PartnerssupportingStrategic or Co-development PartnerStrategic ecosystem partners that complement Expert Insights' advisory capabilities and enable comprehensive service delivery across the healthcare value chain.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Lazard: Global investment bank with a long-standing Healthcare and Life Sciences M&A advisory practice serving pharma, biotech, medtech, and healthcare services clients; overlaps with Expert Insights on healthcare M&A mandates and value-creation advisory for sponsors and strategics, though at a much larger scale and broader scope.
• Houlihan Lokey: Independent investment bank with strong middle-market M&A advisory franchise including a dedicated Healthcare & Life Sciences group offering sell-side, buy-side, and due diligence services that directly compete with Expert Insights' transaction advisory capabilities for healthcare sponsors.
• Leerink Partners: Healthcare-focused investment bank offering strategic advisory, equity research, and capital markets services to healthcare and life sciences companies and sponsors; competes with Expert Insights on healthcare M&A mandates, though with deeper equity capital markets capability.
• William Blair: Global investment bank with a dedicated Healthcare & Life Sciences investment banking practice offering M&A advisory and equity capital markets services; overlaps with Expert Insights on healthcare transaction mandates and serves many of the same financial sponsors and strategic operator clients.

Direct peers

• Lincoln International: Mid-market M&A advisory firm with deep Healthcare and Life Sciences coverage providing buy-side, sell-side, and capital advisory services; serves financial sponsors and strategic operators in pharma services and healthcare — a near-direct comparison to Expert Insights' deal-oriented offering.
• Cascadia Capital: Middle-market investment bank with a specialized Healthcare and Life Sciences practice providing sell-side M&A, recapitalizations, and strategic advisory to healthcare companies and PE sponsors — overlapping directly with Expert Insights' transaction advisory and sponsor-focused model.
• Brown Gibbons Lang & Company: Independent middle-market investment bank with dedicated Healthcare & Life Sciences practice providing buy-side, sell-side, and recapitalization advisory; comparable in size, sector focus, and sponsor client mix to Expert Insights Advisors.
• Livingstone Partners: International mid-market M&A advisory firm with a dedicated Healthcare sector practice providing sell-side, buy-side, and debt advisory to healthcare companies and sponsors — directly comparable in size, sector focus, and transaction orientation.
• Stout: Global advisory firm with a Healthcare & Life Sciences practice offering M&A advisory, transaction advisory services, and due diligence support to healthcare companies and financial sponsors; provides comparable transaction and consulting services across pharma services and life sciences.
• TripleTree: Healthcare-focused investment bank providing M&A advisory and capital raising services to healthcare technology, services, and life sciences companies; highly comparable to Expert Insights given its healthcare-only sector focus and enterprise client base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/expert-insights-consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Expert Insights Advisors